Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis–infected Individuals

Rationale: An effective new tuberculosis (TB) vaccine regimen must be safe in individuals with latent TB infection (LTBI) and is a priority for global health care. Objectives: To evaluate the safety and immunogenicity of a leading new TB vaccine, recombinant Modified Vaccinia Ankara expressing Antig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sander, Clare R., Pathan, Ansar A., Beveridge, Natalie E. R., Poulton, Ian, Minassian, Angela, Alder, Nicola, Van Wijgerden, Johan, Hill, Adrian V. S., Gleeson, Fergus V., Davies, Robert J. O., Pasvol, Geoffrey, McShane, Helen
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2009
Assuntos:
E. Tuberculosis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2858810/
https://ncbi.nlm.nih.gov/pubmed/19151191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.200809-1486OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados